Skip to Content

New Drug Approvals Archive - September 2013

September 2013

Botox Cosmetic (onabotulinumtoxinA)

New Indication Approved: September 11, 2013

Trintellix (vortioxetine) Tablets - formerly Brintellix

Date of Approval: September 30, 2013
Company: Takeda Pharmaceutical Company Limited and H. Lundbeck A/S
Treatment for: Depression

Trintellix (vortioxetine) is a multimodal antidepressant for the treatment of major depressive disorder (MDD).

New Drug Approvals Archive

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.